These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 31915998)

  • 21. Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study.
    Kuwahara T; Abe M; Yamaki M; Fujieda H; Abe Y; Hashimoto K; Ishiba M; Sakai H; Hishikari K; Takigawa M; Okubo K; Takagi K; Tanaka Y; Nakajima J; Takahashi A
    J Cardiovasc Electrophysiol; 2016 May; 27(5):549-54. PubMed ID: 26766541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and Efficacy of Direct Oral Anticoagulants in Patients With Moderate to Severe Cirrhosis.
    Oldham M; Palkimas S; Hedrick A
    Ann Pharmacother; 2022 Jul; 56(7):782-790. PubMed ID: 34553626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis.
    Hum J; Shatzel JJ; Jou JH; Deloughery TG
    Eur J Haematol; 2017 Apr; 98(4):393-397. PubMed ID: 28009449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct Oral Anticoagulants Versus Warfarin for Treatment of Thrombosis or Atrial Fibrillation in Patients With Cirrhosis: A Retrospective Cohort Study.
    Coons EM; Staubes BA; Casey AL; Elagizi-Youssef SA; Mohammed AE; Sharma N; Kline ER
    Ann Pharmacother; 2022 May; 56(5):533-540. PubMed ID: 34470525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use.
    Lee SR; Choi EK; Kwon S; Jung JH; Han KD; Cha MJ; Oh S; Lip GYH
    Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e005894. PubMed ID: 32160790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of direct oral anticoagulants vs warfarin in patients with chronic liver disease and atrial fibrillation.
    Goriacko P; Veltri KT
    Eur J Haematol; 2018 May; 100(5):488-493. PubMed ID: 29444357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Polypharmacy and P-Glycoprotein- and CYP3A4-Modulating Drugs on Safety and Efficacy of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation.
    Harskamp RE; Teichert M; Lucassen WAM; van Weert HCPM; Lopes RD
    Cardiovasc Drugs Ther; 2019 Oct; 33(5):615-623. PubMed ID: 31520256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation Study.
    Admassie E; Chalmers L; Bereznicki LR
    J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):329-336. PubMed ID: 29642709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rivaroxaban vs. warfarin on extended deep venous thromboembolism treatment: A cost analysis.
    Diken AI; Yalçınkaya A; Hanedan MO; Erol ME; Ercen Diken Ö
    Phlebology; 2018 Feb; 33(1):53-59. PubMed ID: 28056701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
    Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?
    Kuo L; Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Left Ventricular Hypertrophy: Insights From the ARISTOTLE Trial.
    Al-Khatib SM; Mulder H; Wojdyla D; Lopes RD; Wallentin L; Alexander JH; Hijazi Z; Goto S; Granger CB
    Circ Arrhythm Electrophysiol; 2021 Mar; 14(3):e009614. PubMed ID: 33657831
    [No Abstract]   [Full Text] [Related]  

  • 33. Management of anticoagulation with rivaroxaban in trauma and acute care surgery: Complications and reversal strategies as compared to warfarin therapy.
    Myers SP; Dadashzadeh ER; Cheung J; Alarcon L; Kutcher M; Brown JB; Neal MD
    J Trauma Acute Care Surg; 2017 Mar; 82(3):542-549. PubMed ID: 28045742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study.
    Durand M; Schnitzer ME; Pang M; Carney G; Eltonsy S; Filion KB; Fisher A; Jun M; Kuo IF; Renoux C; Paterson JM; Quail J; Matteau A;
    CMAJ Open; 2020; 8(4):E877-E886. PubMed ID: 33355273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in Anticoagulant Utilization Among United States Nursing Home Residents With Atrial Fibrillation From 2011 to 2016.
    Alcusky M; McManus DD; Hume AL; Fisher M; Tjia J; Lapane KL
    J Am Heart Assoc; 2019 May; 8(9):e012023. PubMed ID: 31046504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Oral Anticoagulants on Patients With Atrial Fibrillation Aged 90 Years and Older: Comparison Among Direct Oral Anticoagulant, Warfarin Anticoagulant, and Nonanticoagulation.
    Yamaji H; Higashiya S; Murakami T; Hina K; Kawamura H; Murakami M; Kamikawa S; Hirohata S; Kusachi S
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):246-254. PubMed ID: 31498193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of well managed warfarin. A report from the Swedish quality register Auricula.
    Sjögren V; Grzymala-Lubanski B; Renlund H; Friberg L; Lip GY; Svensson PJ; Själander A
    Thromb Haemost; 2015 Jun; 113(6):1370-7. PubMed ID: 25716771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and Safety of Direct Oral Anticoagulants vs Warfarin in Patients with Chronic Kidney Disease and Dialysis Patients: A Systematic Review and Meta-Analysis.
    Chen HY; Ou SH; Huang CW; Lee PT; Chou KJ; Lin PC; Su YC
    Clin Drug Investig; 2021 Apr; 41(4):341-351. PubMed ID: 33709339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of direct oral anticoagulants compared to warfarin in cirrhotic patients with atrial fibrillation.
    Yoo SY; Kim E; Nam GB; Lee D; Shim JH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Choi J
    Korean J Intern Med; 2022 May; 37(3):555-566. PubMed ID: 35078306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrospective comparison of low molecular weight heparin vs. warfarin vs. oral Xa inhibitors for the prevention of recurrent venous thromboembolism in oncology patients: The Re-CLOT study.
    Alzghari SK; Seago SE; Garza JE; Hashimie YF; Baty KA; Evans MF; Shaver C; Herrington JD
    J Oncol Pharm Pract; 2018 Oct; 24(7):494-500. PubMed ID: 28714376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.